在治疗儿童渐进性家族性肝内胆固醇病的新希望
Lama Ebrahim Mkarem1, Mohammed Ali Hosny Batika1, Rana Bitar2,3
1Department of Paediatrics, Sheikh Khalifa Medical City, Abu Dhabi 767451, United Arab Emirates.
World journal of hepatology
|August 1, 2025
概括
渐进性家族性肝内胆固醇症 (PFIC) 是儿童罕见的肝病. 胆汁酸转运体 (IBAT) 抑制剂提供了潜在的非手术治疗,以减少胆汁酸的积累和改善症状.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 儿科胃肠病学 儿科胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 渐进性家族性肝脏内胆固醇症 (PFIC) 包括罕见的,在儿童中以胆汁流失 (胆固醇症) 为特征的遗传性肝脏疾病.
- PFIC导致胆汁酸积累,肝炎,和渐进性肝损伤,在历史上,除了支持性护理之外,治疗选择有限.
- 手术胆道转移已经通过中断胆酸肠肝循环,改善肝功能和生活质量,显示出有效性.
研究的目的:
- 介绍13种不同类型的渐进性家族性肝内胆固醇症 (PFIC).
- 审查目前关于叶胆酸载体 (IBAT) 抑制剂在治疗儿科PFIC患者中的疗效的证据.
- 通过向胆酸代谢来探索PFIC的非手术治疗策略.
主要方法:
- 关于PFIC和IBAT抑制剂的现有研究的文献综述.
- 对临床试验数据的分析和关于在儿科患者群体中使用IBAT抑制剂的病例报告.
- 对PFIC进行手术和非手术干预的比较评估.
主要成果:
- 在PFIC中,IBAT抑制显示出降低血清胆酸和缓解的潜力.
- 手术胆道转移已被证明有效地使胆酸正常化,减少肝损伤,提高患者的生活质量.
- 有证据表明IBAT抑制剂代表了一种有前途的非手术方法来中断胆酸肠肝循环.
结论:
- IBAT抑制剂通过调节胆酸循环,为管理PFIC提供了一种新的非手术治疗途径.
- 需要进一步的研究和临床试验,以确定IBAT抑制剂在不同PFIC亚型中的长期疗效和安全性.
- 向叶胆酸载体提供了一个有希望的策略,以改善PFIC儿童的治疗结果.
相关概念视频
01:29Chronic Pancreatitis II: Collaborative Care
128
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
128
01:24Cystic Fibrosis: Management
224
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
224
01:29Inflammatory Bowel Disease IV: Pharmacological Management
193
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
193
01:26Diseases of the Liver and Gallbladder
1.0K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.0K
01:24Chronic Pancreatitis I: Introduction
162
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
162